Latham & Watkins advised scPharmaceuticals on the deal. scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises Performance Livestock Analytics in funding and separation from Zoetis. Performance Livestock Analytics (PLA), an independent precision livestock platform using cattle data and...
You must be a Standard 1 Year member to access this content.
Latham & Watkins Advises TLM in Acquisition by Endava. Endava, a global provider of digital transformation, agile development and intelligent automation services, acquired TLM Partners, Inc...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised YES on the transaction. Yield Engineering Systems (YES) has announced a $55 million IP-backed financing from a fund managed by Aon Advantage...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Gornitzky & Co. advise Hercules on the financing. Tipalti announced it has raised $150 million in incremental growth financing from JPMorgan Chase...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Alphatec in the transactions. Alphatec Holdings, Inc. (Nasdaq: ATEC), a medical technology company focusing on surgical treatment for spinal disorders has...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Hercules in the transaction. Tricida, Inc. (Nasdaq: TCDA) has entered into a debt facility with Hercules Capital, Inc. (NYSE: HTGC), a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Alphatec in the transaction. Alphatec Holdings, Inc. (Alphatec) announced the close of an asset-based revolving credit facility in the maximum aggregate amount...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Alignment Healthcare in the transaction. Alignment Healthcare, Inc.(Alignment Healthcare) (NASDAQ: ALHC), a leading tech-enabled MedicareAdvantage company, has announced the close of an...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised BridgeBio on the deal. BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, has entered into...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Innocoll Biotherapeutics in the transaction. Innocoll Biotherapeutics plc, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, has announced the successful...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented BridgeBio in the transaction. BridgeBio Pharma (Nasdaq: BBIO) (BridgeBio or the Company), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, executed a...
You must be a Standard 1 Year member to access this content.
